Hyun Kim

846 posts

Hyun Kim banner
Hyun Kim

Hyun Kim

@adapthyun

radiation oncologist, innovator, clinical trialist, father, GI oncology @WashURadOnc

St Louis, MO Katılım Ekim 2018
331 Takip Edilen1.1K Takipçiler
Hyun Kim retweetledi
Terry Williams
Terry Williams@TeWilliamsMD·
Great talk at #MRPTS26 on managing RPT emergencies by Dr. Hyun Kim @adapthyun with a call/need for RadOnc and RPT physicians to own toxicities related to the RPTs they prescribe/administer. @cityofhope
Terry Williams tweet media
English
1
3
16
778
Hyun Kim
Hyun Kim@adapthyun·
Appreciate this fantastic opportunity! (Has been a minute since I signed onto twitter/x so sorry for the very delayed response). @COH_RadOnc and @TeWilliamsMD has been nothing short of stellar in their welcome.
Terry Williams@TeWilliamsMD

We’re thrilled to welcome @adapthyun to @COH_RadOnc! Dr. Hyun Kim is an internationally-recognized thought leader in GI cancer, adaptive radiation therapy & radiopharmaceuticals, and will lead our GI RadOnc & #theranostics programs. #radonc @cityofhope @NRGonc @ASTRO_org

English
1
0
6
389
Hyun Kim retweetledi
KoreanASTRO
KoreanASTRO@KoreanASTRO·
Our final speaker for the KOSRO-KASTRO session is Dr @jihyunRadOnc who will provide the latest evidence and advancements for treating refractory ventricular tachycardia. See you tomorrow 8am Room 314!
KoreanASTRO tweet mediaKoreanASTRO tweet media
English
0
3
9
876
Terry Williams
Terry Williams@TeWilliamsMD·
Looking forward to Dr. Kim’s start at @cityofhope soon to lead our #radonc RPT/theranostics clinical program.
San Francisco, CA 🇺🇸 English
1
1
4
108
Terry Williams
Terry Williams@TeWilliamsMD·
Fantastic workshop @ASTRO_org Annual Mtg on implementing an #RPT from #radbio basics, clinical translation, billing/coding and much more. Great prelude to ASTROs RPT symposium in Feb 2026. Enjoying the talk from Dr. Hyun Kim about developing a collaborative model with NucMed!
Terry Williams tweet media
San Francisco, CA 🇺🇸 English
3
1
8
624
Hyun Kim
Hyun Kim@adapthyun·
Thanks @MikeChuongMD @sueyom! It was a privilege to work under your leadership. @IJROBP Now time to change my email address before the reviewer invites start coming in 😁
Michael Chuong@MikeChuongMD

🤩 What a truly amazing group of human beings!! So sorry to miss this as I was giving a talk at #ASTRO25 Excited to announce our new @IJROBP GI associate editors @LCUBLD @AitkenKatharine 🙌 Much gratitude to @adapthyun & Andrzej Wojcieszynski who are rotating off 🙏

English
0
1
14
1.6K
Hyun Kim
Hyun Kim@adapthyun·
@jryckman3 @NiuSanford Also if the toxicity is higher in the LCCRT arm, will US providers attribute it to the oxaliplatin and continue to use LCCRT without oxali?
English
0
0
2
31
Jeff Ryckman
Jeff Ryckman@jryckman3·
NOM-ERA sets a high bar. Excellent work. Can’t wait for ACO/ARO/AIO-18 to help settle the classic LCRT vs. SCRT NOM question once and for all! 😉 #ASTRO25 #CRCSM
Jeff Ryckman tweet media
English
2
8
22
1.5K
Dr. Nina Niu Sanford
Dr. Nina Niu Sanford@NiuSanford·
And the plot thickens for short course RT in rectal cancer! 72% cCR & 57% 2-year TME free survival via 4 cycles FOLFOX/CAPOX --> 25-30Gy/5 fraction RT (short course with optional boost). Congrats @adapthyun & looking forward to study details. #ASTRO25
Dr. Nina Niu Sanford tweet media
Jeff Ryckman@jryckman3

NOM-ERA results just dropped! 🔥 #ASTRO25 Awesome work @adapthyun et al! Wondering if those who got the optional 30 Gy × 5 primary tumor boost had larger tumors or more adverse features since cCR and TME-free survival looked similar overall. sciencedirect.com/science/articl…

English
5
31
82
12.1K
Hyun Kim
Hyun Kim@adapthyun·
@jryckman3 @NiuSanford Thanks @jryckman3! I'm eagerly awaiting the AIO-18 results as well. My concern is that they allow chemotherapy to start 1.5 weeks after SCRT ends. Our institutional data (any anecdotal experience) indicate that this may result in more G3+ toxicity.
English
0
0
1
21